AL AMYLOIDOSIS
Clinical trials for AL AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AL AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to dissolve amyloid lumps in rare disease
Disease control Not yet recruitingThis early study tests a drug called CAEL-101/anselamimab in 5 adults with AL amyloidoma, a condition where abnormal protein builds up in tissues. The goal is to see if the drug binds to these deposits and helps shrink them. Participants will have imaging scans over 72 weeks to t…
Matched conditions: AL AMYLOIDOSIS
Phase: EARLY_PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Not yet recruitingThis study looks at how to safely test for allergic reactions to biotherapies (special drugs used to treat cancer and other diseases). Researchers will test different concentrations of these drugs on the skin of 70 cancer patients who have not had allergic reactions, to find the …
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC